BEGIN:VCALENDAR
VERSION:2.0
X-WR-CALNAME;VALUE=TEXT:Use of Human Stem Cell-derived Retinal Cells to Identify Novel Therapeutics Molecules for Glaucoma and Retinal Degenerative Disease
PRODID:-//Harvard events data//EN
BEGIN:VEVENT
UID:event_264836_0
SUMMARY:Use of Human Stem Cell-derived Retinal Cells to Identify Novel Therapeutics Molecules for Glaucoma and Retinal Degenerative Disease
DESCRIPTION:<p>Genetic and Regenerative Medicine of Eye Disease | Organized by the Ocular Regenerative Medicine Institute (ORMI) &amp; Ocular Genomics Institute (OGI)</p><p><strong>Guest speaker:</strong><br><em><strong>Donald Zack, MD, PhD</strong></em><br>Johns Hopkins School of Medicine<br><br>The Ocular Regenerative Medicine Institute (ORMI) &amp; Ocular Genomics Institute (OGI) invites you to the 2nd annual "Genetic &amp; Regenerative Medicine of Eye Disease" lecture series. The faculty organizers are Neena Haider, PhD, Luk H. Vandenberghe, PhD, and Michael Young, PhD. <br><br>This seminar series will address such topics as: genetics, gene therapy and regenerative medicine relevant to ophthalmology and will feature renowned scholars with international reputation. Please find in attachment the schedule and list of speakers invited to Schepens, Mass Eye and Ear and the HMS Department of Ophthalmology. To the extent possible, each speaker will be able to meet with select faculty and fellows. <br><br>Please contact Semion Kasuli (semion_kasuli@meei.harvard.edu) or Mary Wheeler (mary_wheeler@meei.harvard.edu) with any questions or inquiries.</p>
LOCATION:Massachusetts Eye and Ear Infirmary, Meltzer Auditorium, 243 Charles Street, Boston, MA 02114
STATUS:CONFIRMED
DTSTART:20141203T210000Z
DTEND:20141203T220000Z
END:VEVENT
END:VCALENDAR